Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses

Mostrar otras versiones (1)

The emergence of SARS-CoV-2 and the ensuing explosive epidemic of COVID-19 disease has generated a need for assays to rapidly and conveniently measure the antiviral activity of SARS-CoV-2–specific antibodies. Here, we describe a collection of approaches based on SARS-CoV-2 spike-pseudotyped, single-...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Fabian, Weisblum, Yiska, Muecksch, Frauke, Hoffmann, Hans-Heinrich, Michailidis, Eleftherios, Lorenzi, Julio C.C., Mendoza, Pilar, Rutkowska, Magdalena, Bednarski, Eva, Gaebler, Christian, Agudelo, Marianna, Cho, Alice, Wang, Zijun, Gazumyan, Anna, Cipolla, Melissa, Caskey, Marina, Robbiani, Davide F., Nussenzweig, Michel C., Rice, Charles M., Hatziioannou, Theodora, Bieniasz, Paul D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2020
Materias:
Technical Advances and Resources
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372514/
https://www.ncbi.nlm.nih.gov/pubmed/32692348
http://dx.doi.org/10.1084/jem.20201181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372514/
https://www.ncbi.nlm.nih.gov/pubmed/32692348
http://dx.doi.org/10.1084/jem.20201181

Ejemplares similares